Nukleus Office Solutions Limited has provided prior intimation of a Board of Directors meeting scheduled for Saturday, August 29, 2026. The meeting will consider and approve the following business items:
- Formulation and approval of the Employee Stock Option Plan / Scheme, 2026, specifically the NUKLEUS OFFICE SOLUTIONS LIMITED ESOP Scheme-I 2026, subject to shareholder approval and relevant regulatory authorities' approval
- Approval of the draft notice of the General Meeting to seek necessary shareholder approvals for the ESOP scheme
- Any other business items with the permission of the Chair
The disclosure is made pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additionally, in compliance with the Company's Code of Conduct for Prevention of Insider Trading framed under the SEBI (Prohibition of Insider Trading) Regulations, the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons and their immediate relatives. The closure period extends until 48 hours after the conclusion/outcome of the scheduled Board Meeting.